BlackRock, Inc.

Holdings History for Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)

Symbol: AKBA on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 19,219,819 shares
Security Ownership %: 7.2%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in Akebia Therapeutics, Inc. COMMON STOCK (AKBA)

21 Jan 2026 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 19,219,819 shares of Akebia Therapeutics, Inc. COMMON STOCK (AKBA). This represents 7.2% ownership of the company. In their previous filing dated 17 Apr 2025, BlackRock, Inc. had reported owning 15,141,768 shares, indicating an increase of +27%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BlackRock, Inc.	7.2%	+18%	$30,943,909	19,219,819	+4,078,051	+27%	$1.61	13G/A	31 Dec 2025	21 Jan 2026, 12:30
BlackRock, Inc.	6.1%		$34,523,231	15,141,768			$2.28	13G/A	31 Mar 2025	17 Apr 2025, 09:35

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$31,102,707	19,318,452	+521,394	+2.8%	$1.61	Q4 2025
30 Sep 2025	0%	+0%	$51,315,969	18,797,058	+423,097	+2.3%	$2.73	Q3 2025
30 Jun 2025	0%	+0%	$66,881,218	18,373,961	+3,041,798	+20%	$3.64	Q2 2025
31 Mar 2025	0%	+0%	$29,437,752	15,332,163	+234,538	+1.6%	$1.92	Q1 2025
31 Dec 2024	0%	-0%	$28,685,488	15,097,625	-99,582	-0.66%	$1.90	Q4 2024
30 Sep 2024	0%	0%	$20,060,314	15,197,207	0		$1.32	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.